Activated aggregation-induced emission therapeutics agents for triggering regulated cell death

Yu Qiang Zhao, Le Yu, Lanyun Zhang, Huan Liu, Ying Zhou, Jong Seung Kim

Research output: Contribution to journalReview articlepeer-review


The induction of regulated cell death (RCD) through photo/ultrasound sensitization therapeutic agents has gained significant attention as a vital approach to combat drug resistance in tumors. Aggregation-induced emission (AIE) therapeutic agents generate reactive oxygen species through photo/ultrasound activation, which can synergize with RCD inducers or directly induce RCD, ultimately resulting in the death of tumor cells. The presented comprehensive review delves into recent advancements in AIE therapeutic agents designed to trigger RCD or synergize with RCD inducers, encompassing apoptosis, necroptosis, pyroptosis, immunogenic cell death, autophagy, ferroptosis, and cuproptosis. Additionally, the intricate regulatory mechanisms through which activatory-AIE therapeutics influence distinct RCD pathways are examined. A forward-looking perspective on future developments and pertinent challenges within this exciting realm is presented, anticipating the continued evolution of activatable AIE therapeutics as a transformative approach to enhance tumor therapy.

Original languageEnglish
Publication statusAccepted/In press - 2024

Bibliographical note

Publisher Copyright:
© 2024 The Authors. Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.


  • aggregation-induced emission
  • phototherapy
  • regulated cell death
  • sonodynamic therapy
  • therapeutic agents

ASJC Scopus subject areas

  • Chemistry (miscellaneous)
  • Materials Science (miscellaneous)
  • Materials Chemistry
  • Molecular Biology


Dive into the research topics of 'Activated aggregation-induced emission therapeutics agents for triggering regulated cell death'. Together they form a unique fingerprint.

Cite this